Case Report

Post-operative agranulocytosis caused by intravenous cefazolin: A case report with a discussion of the pathogenesis

Charles M Lombard*, Jiali Li and Bijayee Shrestha

Published: 18 February, 2022 | Volume 6 - Issue 1 | Pages: 009-012

A case of post-operative agranulocytosis which occurred in a 66-year-old woman following surgery for endometrial carcinoma is reported. The agranulocytosis had a rapid onset, being detected on the first post-operative day. The causative agent, cefazolin was given to the patient intraoperatively. The agranulocytosis persisted until the 22nd postoperative day. A bone marrow biopsy performed on post-operative day four showed a left-shifted myeloid maturation pattern but not a maturation arrest. The pathogenesis of drug-induced neutropenia/agranulocytosis is discussed. It is postulated that reversible binding of cefazolin to albumin accounts for the prolonged duration of agranulocytosis.

Read Full Article HTML DOI: 10.29328/journal.apcr.1001030 Cite this Article Read Full Article PDF


Agranulocytosis; Neutropenia; Postoperative; Cephalosporin; Cephazolin; Pathogenesis


  1. Andersohn F, Konzen C, Garbe E. Systemic review: Agranulocytosis induced by nonchemotherapy drugs. Ann Internal Med 2007; 146: 657-665. PubMed: https://pubmed.ncbi.nlm.nih.gov/17470834/
  2. Uetrecht J, Naisbitz DJ. Idiosyncratic adverse drug reactions: Current Pharmacol Rev. 2013; 65: 779-808. PubMed: https://pubmed.ncbi.nlm.nih.gov/23476052/
  3. Curtis BR. Non-chemotherapy drugs-induced neutropenia: Key points to manage the challenges. Hematology Am Soc Hematol Educ Program. 2017; 2017: 187-193. PubMed: https://pubmed.ncbi.nlm.nih.gov/29222255/
  4. Rattay B, Benndorf RA. Drug-induced idiosyncratic agranulocytosis-infrequent but dangerous. Fronti Pharmacol. 2021; 12: 1-13. PubMed: https://pubmed.ncbi.nlm.nih.gov/34483939/
  5. Smith CR. Cefotaxime and cephalosporins: Adverse reactions in Rev Infect Dis. 1982; 4: S481-S487. PubMed: https://pubmed.ncbi.nlm.nih.gov/6294802/
  6. Murphy MF, Metcalfe P, Grint PCA, et al. Cephalosporin-induced immune neutropenia. Br J Haem. 1985; 59: 9-14. PubMed: https://pubmed.ncbi.nlm.nih.gov/3882133/
  7. Cimino C, Allos BM, Phillips EJ. A review of beta-lactam-associated neutropenia and implications for cross-reactivity. Ann Pharm. 2021; 55: 1037-1049. PubMed: https://pubmed.ncbi.nlm.nih.gov/33215507/
  8. Murphy MF, Riordan T, Minchinton RM, et al. Demonstration of an immune- mediated mechanism of penicillin-induced neutropenia and Br J Haem. 1982; 55: 155-160. PubMed: https://pubmed.ncbi.nlm.nih.gov/6882683/
  9. Uy N, Thiagarajan P, Musher DM. Cephalosporin site chain idiosyncracies: A case report of ceftriaxone-induced agranulocytosis and review of literature. Open Forum Infect Dis. 2015; 2: ofv007. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438888/
  10. Moeschlin S, Wagner K. Agranulocytosis due to the occurrence of leukocyte- agglutinins. Acta Haem. 1952; 8: 29-41. PubMed: https://pubmed.ncbi.nlm.nih.gov/12985212/
  11. Decroix MO, Zini R, Chaumeil JC, Tillement JP. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs. Biochem Pharm. 1988; 37: 2807-2813. PubMed: https://pubmed.ncbi.nlm.nih.gov/3395358/
  12. Vella-Brincat JWA, Begg EJ, Kirkpatrick CMJ, Zhang M, Chambers ST, et al. Protein binding of cefazolin is saturable in vivo both between and within patients. Br J Cin Pharm. 2007; 63: 753-757. PubMed: https://pubmed.ncbi.nlm.nih.gov/17223858/
  13. Zorzi A, Linciano S, Angelini A. Non-covalently albumin-binding ligands for extending the circulating half-life of small biotherapeutics. Med Chem Commun. 2019; 10: 1068-1081. PubMed: https://pubmed.ncbi.nlm.nih.gov/31391879/
  14. Getta B, Ponnian G, Ling S. Intravenous immunoglobulin induces short-term reversal of drug-induced autoimmune neutropenia." Letter to editor. Transfus Med. 2015; 25: 347-348. PubMed: https://pubmed.ncbi.nlm.nih.gov/26192766/
  15. Jacob S, Rajabally YA. Currant proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies. Curr Neuropharmacol. 2009; 7: 337-342. PubMed: https://pubmed.ncbi.nlm.nih.gov/20514213/
  16. Norris PAA, Kaur G, Lazarus AH. New insight into intravenous immunoglobulin mechanisms and alternatives in autoimmune and inflammatory diseases. Curr Opin Hematol. 2020; 27: 392-398. PubMed: https://pubmed.ncbi.nlm.nih.gov/32868670/


Similar Articles

Recently Viewed

Read More

Most Viewed

Read More